| Identification | Back Directory | [Name]
1-Pentanone, 1-(4-hydroxy-3-methoxyphenyl)-2-(1-pyrrolidinyl)-, hydrochloride (1:1) | [CAS]
2748590-34-1 | [Synonyms]
1-(4-hydroxy-3-methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one,monohydrochloride
1-Pentanone, 1-(4-hydroxy-3-methoxyphenyl)-2-(1-pyrrolidinyl)-, hydrochloride (1:1) | [Molecular Formula]
C16H23NO3.ClH | [MOL File]
2748590-34-1.mol | [Molecular Weight]
313.82 |
| Hazard Information | Back Directory | [Description]
3,4-MDPV metabolite 1 is produced during phase I metabolism of 3,4-MDPV.1,2 This compound can be further modified, e.g., by glucuronidation, before secretion in urine.1 This product is intended for forensic and research purposes.WARNING This product is not for human or veterinary use. | [References]
[1] SABINA STRANO-ROSSI. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry[J]. Rapid Communications in Mass Spectrometry, 2010, 24 18: 2706-2714. DOI: 10.1002/rcm.4692
[2] MARKUS R. MEYER. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS[J]. Journal of Mass Spectrometry, 2010, 45 12: 1426-1442. DOI: 10.1002/jms.1859 |
|
|